(Q43747318)

26 November 2017

title

Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease (English)

1 reference

26 November 2017

Wilkinson D

1

1 reference

26 November 2017

Murray J

series ordinal

2

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

International Journal of Geriatric Psychiatry

26 November 2017

published in

1 reference

26 November 2017

volume

16

1 reference

26 November 2017

issue

9

1 reference

26 November 2017

page(s)

852-857

1 reference

26 November 2017

1 reference

Selective loss of central cholinergic neurons in Alzheimer's disease

21 January 2018

1 reference

21 January 2018

1 reference

The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease.

21 January 2018

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

21 January 2018

1 reference

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

21 January 2018

1 reference

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

21 January 2018

1 reference

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/GPS.409

1 reference

26 November 2017

1 reference